OCREVUS® (ocrelizumab) dosing and administration

Twice-yearly dosing schedule 4*

Learn more about the dosing schedule needed for your patients to start on OCREVUS (ocrelizumab).

Adherence data with OCREVUS

Patient adherence & persistence

See data from 2 years of controlled and 1 year of real-world study of twice-yearly OCREVUS*

Managing infusion-related reactions

Infusion-related reactions

See OCREVUS infusion-related reaction data and the recommendations for managing infusion-related reactions.

Infusion training

OCREVUS infusion training

The OCREVUS infusion training module provides information about how to administer OCREVUS to patients with RMS or PPMS.

The Infusion Center Locator is non-medication and non-disease specific, so it contains sites that may not infuse OCREVUS or that may not be covered by a particular patient's insurance provider.
DMT=disease-modifying therapy; PPMS=primary progressive multiple sclerosis; RMS=relapsing multiple sclerosis.